Sugi Predict

Sugi Predict / Compounds / SCHEMBL18654342

SCHEMBL18654342

SCHEMBL18654342

NCCO[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](OC(=O)c5ccccc5)[C@H](OC(=O)c5ccccc5)[C@H]4OC(=O)c4ccccc4)[C@@H](OC(=O)c4ccccc4)[C@H](OC(=O)c4ccccc4)[C@H]3OC(=O)c3ccccc3)[C@@H](OC(=O)c3ccccc3)[C@H](OC(=O)c3ccccc3)[C@H]2OC(=O)c2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 2/20 0.46
▸ LGALS9 O00182 1/20 0.46
▸ LGALS1 P09382 1/20 0.46
▸ LGALS7; LGALS7B P47929 1/20 0.46
▸ MAOB P27338 1/20 0.42
▸ USP2 O75604 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PTPN1 P18031 8/20 0.40
▸ SELP P16109 3/20 0.40
▸ IGF2R P11717 1/20 0.40
▸ TMPRSS2 O15393 1/20 0.39
▸ PDE5A O76074 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ HMGCR P04035 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ LCK P06239 1/20 0.39
▸ FYN P06241 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18654240 1.00 LGALS3 (0.46) LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB
SCHEMBL18654302 0.91 PTPN1 (0.50) USP2MEN1POLBKMT2APTPN1
SCHEMBL6220071 0.87 PTPN1 (0.53) LGALS3LGALS9LGALS1LGALS7; LGALS7BUSP2
SCHEMBL6220068 0.87 PTPN1 (0.53) LGALS3LGALS9LGALS1LGALS7; LGALS7BUSP2
SCHEMBL30391368 0.87 PTPN1 (0.47) USP2MEN1POLBKMT2APTPN1
SCHEMBL18654301 0.86 LGALS3 (0.50) LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB
SCHEMBL18654247 0.86 LGALS3 (0.50) LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB
SCHEMBL16230374 0.85 LGALS3 (0.46) LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB
SCHEMBL16230372 0.85 LGALS3 (0.46) LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB
SCHEMBL16230371 0.85 LGALS3 (0.46) LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266609-B2 Immunomodulating beta-1,6-D-glucans INNATE BIOTHERAPEUTICS, LLC (US) 2019-04-23 — — US disclosed
US-20170081428-A1 IMMUNOMODULATING BETA-1,6-D-GLUCANS INNATE BIOTHERAPEUTICS, LLC 2017-03-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266609-B2 Immunomodulating beta-1,6-D-glucans IFNG, FUT6, LGALS1 LGALS3 46/4885LGALS9 34/4885LGALS1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback